|
 |
European Pharmaceutical Contractor
|
New Challenges
New acquisitions, increased factory count and global diversity have meant the pharmaceutical industry faces challenges never seen before. In a world of consolidation and increasingly complex independent growth, is it still possible to achieve 100 per cent regulatory compliant GAMP manufacturing?
Can IT Help?
In addition to capacity and new product expansions, there is a continuing wave of industry consolidation. Pharmaceutical companies have become managers of vast, globally dispersed, physical manufacturing assets (such as the Glaxo merger with SmithKline Beecham and the forthcoming Pfizer merger with Pharmacia). To compound matters, regulatory compliance can be a confusing and time-consuming process. While in theory IT can provide global companies with the ability to co-ordinate and optimise the operation of their assets, often it does not.
The trouble is often caused by enterprise resource planning (ERP) deployments with long implementation timecycles (perhaps several years). The ERP deployment time can be significantly longer than the acquisition timecycle. This leads to a situation where the developed strategy is out of date before the system implementation is even complete. The solution is to focus on the rapid deployment of 'best-of-breed' applications that address the business needs and easily integrate with existing IT structures.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Mark Dolphin, General Manager of Datastream Systems
For the last two years, Mark Dolphin has headed up Datastream's UK and Netherlands operations which supply software, consulting services and support to many leading pharmaceutical companies. Mark's focus for the two business units is to implement enterprise-wide asset management (EAM) within the regulated environment of the pharmaceutical industry.
Mark's previous experience is primarily in the process industries, such as oil and gas, chemicals, pharmaceuticals, pulp and paper, plastics, rubber and metals. With Measurex and then Honeywell, he was responsible for the industrial automation business, which included MES systems for production planning, order tracking, quality tracking, warehouse management and process control systems
|
|
|
|
|
|
 |
Industry Events |
 |
Small Scale Biomanufacturing – clinical trials, cell & gene therapies
18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol
This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >> |
|
 |
